Application of liposomes in medicine and drug delivery

Artificial Cells, Nanomedicine and Biotechnology

Volumn 44, Issue 1, 2016, Pages 381-391

  Daraee, Hadis ^b   Etemadi, Ali ^b   Kouhi, Mohammad ^d   Alimirzalu, Samira ^c   Akbarzadeh, Abolfazl ^a,b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c PAYAME NOOR UNIVERSITY   (Iran)

^d ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Commercial products; Liposome; Medical field; Smart delivery

Indexed keywords

BIOCHEMISTRY; LIPOSOMES;

COMMERCIAL PRODUCTS; DRUG DELIVERY VEHICLES; MEDICAL DIAGNOSTICS; MEDICAL FIELDS; PENETRATION ENHANCERS; SIGNAL ENHANCERS; SMART DELIVERY; SOLUBILIZERS;

DIAGNOSIS;

AMIKACIN; AMPHOPHILE; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; CEFTAZIDIME; CHELATING AGENT; CHOLESTEROL; GENTAMICIN; IMMUNOLIPOSOME; LIPOSOME; PHOSPHOLIPID; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTIPROTOZOAL AGENT; COSMETIC; IMMUNOLOGICAL ADJUVANT;

ANTIMICROBIAL THERAPY; CANCER CHEMOTHERAPY; CELLULAR DISTRIBUTION; CYTOSOL; GENE; GENE THERAPY; HUMAN; HYDROPHILICITY; IMMUNE SYSTEM; INFECTION; INTRACELLULAR SIGNALING; LIPOPHILICITY; LIPOSOMAL DELIVERY; MOLECULAR DIAGNOSIS; NONHUMAN; PARASITOSIS; PH; PLASMID; REVIEW; SURFACE PROPERTY; VACCINATION; CHEMICAL PHENOMENA; CHEMISTRY; DRUG DELIVERY SYSTEM; NANOMEDICINE; PROCEDURES; SYNTHESIS;

ADJUVANTS, IMMUNOLOGIC; ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS; ANTIPROTOZOAL AGENTS; COSMETICS; DRUG DELIVERY SYSTEMS; GENETIC THERAPY; HUMANS; HYDROGEN-ION CONCENTRATION; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; LIPOSOMES; NANOMEDICINE; PHOSPHOLIPIDS; VACCINATION;

EID: 84971655160     PISSN: 21691401     EISSN: 2169141X     Source Type: Journal    
DOI: 10.3109/21691401.2014.953633     Document Type: Review

References (47)

1. Allen TM, Chonn A. 1987. Large unilamellar liposomes with low uptake into the reticuloendothelial system. FEBS Lett. 223: 42-46.
2. Allen TM, Mehra T, Hansen C, Chin YC. 1992. Stealth liposomes: an improved sustained release system for D-arabinofuranosylcytosine. Cancer Res. 52: 2431-2439.
3. Allen TM 1994. The use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by the mononuclear phagocyte system. Adv Drug Deliv Rev. 13: 285-309.
4. Alving CR 1991. Liposomes as carriers of antigens and adjuvants. J Immunol Methods. 140: 1-13.
5. Bakker-Woudenberg IA, Storm G, Woodle MC. 1994. Liposomes in the treatment of infections. J Drug Target. 2: 363-371.
6. Bangham AD 1993. Liposomes: the Babraham connection. Chem Phys Lipids. 64: 275-285.
7. Chu CJ, Dijkstra J, Lai MZ, Hong K, Szoka FC. 1990. Efficiency of cytoplasmic delivery by pH-sensitive liposomes to cells in culture. Pharm Rese. 7: 824-834.
8. De Gennes PG. 1987. Polymers at an interface; a simplified view. Adv Colloid Interface Sci. 27: 189-209.
9. Engelhard VH, Powers GA, Moore LC, Holterman MJ, Correa-Freire MC. 1984. Cytotoxic T lymphocyte recognition of HLA-A/B antigens introduced into EL4 cells by cell-liposome fusion. J Immunol. 132: 76-80.
10. Felgner PL, Gadek TR, Holm M, Roman R, Chan HW, Wenz M, et al. 1987. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA. 84: 7413-7417.
11. Fendler JH, Romero A. 1977. Liposomes as drug carriers. Life Sci. 20: 1109-1120.
12. Gabizon A, Papahadjopoulos D. 1988. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc Natl Acad Sci USA. 85: 6949-6953.
13. Gregoriadis G. 1990. Immunological adjuvants: a role for liposomes. Immunol Today. 11: 89-97.
14. Gregoriadis G, Davis D, Davies A. 1987. Liposomes as immunological adjuvants: antigen incorporation studies. Vaccine. 5: 145-151.
15. Gustafsson J, Arvidson G, Karlsson G, Almgren M. 1995. Complexes between cationic liposomes and DNA visualized by cryo-TEM. Biochim Biophy Acta. 1235: 305-312.
16. Hamori CJ, Lasic DD, Vreman HJ, Stevenson DK. 1993. Targeting zinc protoporphyrin liposomes to the spleen using reticuloendothelial blockade with blank liposomes. Pediatr Res. 34: 1-5.
17. Immordino ML, Dosio F, Cattel L. 2006. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomedicine. 1: 297.
18. Juliano RL, Stamp D. 1975. The effect of particle size and charge on the clearance rates of liposomes and liposome encapsulated drugs. Biochem Biophys Res Commun. 63: 651-658.
19. Klibanov AL, Maruyama K, Torchilin VP, Huang L. 1990. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett. 268: 235-237.
20. Kumar A, Badde S, Kamble R, Pokharkar V. 2010. Develepment and characterization of liposomal drug delivery system for nimesulide. Int J Pharm Pharm Sci. 2: 20-27.
21. Lasic DD 1994. Sterically stabilized vesicles. Angew Chem Int Ed Engl. 33: 1685-1698.
22. Lasic DD, Frederik PM, Stuart MC, Barenholz Y, McIntosh TJ. 1992. Gelation of liposome interior. A novel method for drug encapsulation. FEBS Lett. 312: 255-258.
23. Lasic DD, Papahadjopoulos D. 1998. Medical Applications of Liposomes. Amsterdam: Elsevier.
24. Lasic DD 1993. Liposomes: From Physics to Applications. Amsterdam: Elsevier.
25. Lasic DD 1994. Sterically stabilized vesicles. Angew Chem Int Ed Engl. 33: 1690-1699.
26. Lasic, DD. 1994. Sterically stabilized vesicles. Angew Chem Int Ed Engl. 33: 1685-1698.
27. LeGrue SJ 1984. Carrier and adjuvant properties of liposome-borne tumor-specific antigens. Cancer Immunol Immunother. 17: 135-141.
28. Litzinger DC, Huang L. 1992. Phosphatodylethanolamine liposomes: drug delivery, gene transfer and immunodiagnostic applications. Biochim Biophys Acta. 1113: 201-227.
29. Lopez-Berestein G, Fainstein V, Hopfer R, Mehta K, Sullivan MP, Keating M, et al. 1985. Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study. J Infect Dis. 151: 704-710.
30. Machy P, Leserman L. 1987. Liposomes in Cell Biology and Pharmacology. London: J. Libbey & Co.
31. McCalden TA 1990. Particulate systems for drug delivery to the lung. Adv Drug Deliv Rev. 5: 253-263.
32. Mellman I, Fuchs R, Helenius A. 1986. Acidification of the endocytic and exocytic pathways. Annu Rev Biochem. 55: 663-700.
33. New RR, Chance ML, Thomas SC, Peters W. 1978. Antileishmanial activity of antimonials entrapped in liposomes. Nature. 272: 55-56.
34. Ochi A, Shibata S, Mori K, Sato T, Sunamoto J. 1990. Targeting chemotherapy of brain tumor using liposome encapsulated cisplatin. Part 2. Pullulan anchored liposomes to target brain tumor. Drug Deliv Syst. 5: 261-271.
35. Papahadjopoulos D, Allen TM, Gabizon A, Mayhew E, Matthay K, Huang SK, et al. 1991. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc Natl Acad Sci USA. 88: 11460-11464.
36. Papahadjopoulos D. 1978. Liposomes and Their Uses in Biology and Medicine, 308 ed. New York: Academy of Sciences.
37. Poznansky MJ, Juliano RL. 1984. Biological approaches to the controlled delivery of drugs: a critical review. PharmRev. 36: 277-336.
38. Raphael L, Tom BH. 1984. Liposome facilitated xenogeneic approach for studying human colon cancer immunity: carrier and adjuvant effect of liposomes. Clin Exp Immunol. 55: 1.
39. Senior J, Delgado C, Fisher D, Tilcock C, Gregoriadis G. 1991. Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly (ethylene glycol)-coated vesicles. Biochim Biophys Acta. 1062: 77-82.
40. Senior JH 1986. Fate and behavior of liposomes in vivo: a review of controlling factors. Crit Rev Ther Drug Carrier Syst. 3: 123-193.
41. Steele G Jr, Ravikumar T, Ross D, King V, Wilson RE, Dodson T. 1984. Specific active immunotherapy with butanol-extracted, tumor-associated antigens incorporated into liposomes. Surgery. 96: 352-359.
42. Svenson CE, Popescu MC, Ginsberg RC. 1988. Liposome treatments of viral, bact and protozoal infections. Crit Rev Microbiol. 15: S1-S31.
43. Torchilin VP, Shtilman MI, Trubetskoy VS, Whiteman K, Milstein AM. 1994. Amphiphilic vinyl polymers effectively prolong liposome circulation time in vivo. Biochim Biophys Acta. 1195: 181-184.
44. Wang CY, Huang L. 1987. pH-sensitive immunoliposomes mediate target-cell-specific delivery and controlled expression of a foreign gene in mouse. Proc Natl Acad Sci USA. 84: 7851-7855.
45. Weiner N, Martin F, Riaz M. 1989. Liposomes as a drug delivery system. Drug Dev Ind Pharm. 15: 1523-1554.
46. Williams BD, O'sullivan MM, Saggu GS, Williams KE, Williams LA, Morgan JR. 1986. Imaging in rheumatoid arthritis using liposomes labelled with technetium. Br Med J (Clin Res Ed.). 293: 1143.
47. Woodle MC, Storm G, Newman MS, Jekot JJ, Collins LR, Martin FJ, Szoka FC Jr 1992. Prolonged systemic delivery of peptide drugs by long-circulating liposomes: illustration with vasopressin in the Brattleboro rat. Pharm Res. 9: 260-265.